s genomes are sequenced, it is becoming clear that nearly all bacteria and archaea have arsenic-resistance (ars) operons that confer resistance to arsenite [As(III)] and arsenate [As(V)] (1). The widespread occurrence of ars genes reflects the fact that arsenic is a ubiquitous environmental toxic metal. In most cases, these operons encode transport proteins that extrude As(III) from cells. In eukaryotes, As(III) detoxification involves glutathionylation coupled to removal of the As(GS) 3 complex from the cytosol by ABC transporters, such as the Saccharomyces cerevisiae Ycf1p vacuolar pump (2) or mammalian biliary extrusion pump MRP2 (3) . In many mammals, including humans, an alternate metabolic fate of As(III) is methylation in the liver, followed by urinary excretion of the methylated species (4) . In the past, this process was considered a detoxification mechanism (5) , but more recent data suggest that the methylation actually increases toxicity by producing the more toxic monomethylarsenite [MMA(III)] and dimethylarsenite [DMA(III)], calling into question whether the process is, in fact, a detoxification process (6) . An enzyme (termed Cyt19 or As3MT) that catalyzes As(III)-S-adenosylmethyltransferase activity has been identified recently in rats and humans (7) (8) (9) . The enzyme has been characterized in vitro, but its physiological role is unknown.
Bacteria and fungi are known to produce volatile and toxic arsines (10) but the physiological roles of arsenic methylation in microorganisms are likewise unclear, and the biochemical basis is unknown. While examining microbial genomes, we identified large number of genes for bacterial and archaeal homologues of Cyt19. We have termed a subset of these genes arsM and their protein product ArsM (As(III) S-adenosylmethyltransferase). What sets these arsM genes apart from genes for other homologues is that they are each downstream of an arsR gene, encoding the archetypal arsenic-responsive transcriptional repressor that controls expression of ars operons (11) , suggesting that these ArsMs evolved to confer arsenic resistance.
The gene for the 283-residue ArsM (29,656 Da) (accession no. NP948900.1) was cloned from Rhodopseudomonas palustris and expressed in an arsenic-hypersensitive strain of Escherichia coli. As(III)-resistance cells in E. coli expressing recombinant arsM correlated with conversion of medium arsenic to the methylated pentavalent species DMA(V) and TMAO and to trimethylarsine [TMA(III)] gas. In vivo, the toxicity of inorganic and organic arsenicals is DMA(III),MMA(III) Ͼ As(III) Ͼ As(V) Ͼ DMA(V), MMA(V) Ͼ TMAO (12) . The major pentavalent products DMA(V) and TMAO are approximately 100-fold and a 1,000-fold, respectively, less toxic than As(III) (13) . Although MMA(III) and DMA(III) are more toxic than As(III), they do not accumulate in cells expressing arsM. Whereas TMA(III) is more toxic than As(III), its volatility prevents its accumulation in cells expressing arsM. The recombinant protein was purified and shown to catalyze transfer of methyl groups from Sadenosylmethionine (AdoMet) to As(III), forming di-and trimethylated species. The final product was TMA(III) gas. These results demonstrate that methylation of environmental arsenic by conversion to soluble and gaseous methylated species is a detoxifying process that may contribute to global cycling of arsenic.
Results

Expression of arsM Is Transcriptionally Regulated by As(III).
To date, 125 bacterial and 16 archaeal ArsM homologues have been identified, most likely AdoMet methyltranferases but of unknown physiological function. The methyltransferases were recently classified into two groups, UbiE͞Coq5 S-adenosyl-Lmethionine-dependent C-methyltransferase and MmtA-like Sand O-methyltransferases (14) . Of these, 12 homologues that belong to the UbiE group (see Fig. 6 , which is published as supporting information on the PNAS web site) are adjacent to arsR genes, which have been shown to control expression of arsenic-resistance operons (11) , implying that their gene products, termed ArsM, play a role in arsenic detoxification. The 12 organisms are diverse, including bacteria and archaea, aerobes and anaerobes, mesophiles, thermophiles, and halophiles. We chose the homologue from the Gram-negative soil bacterium R. palustris to characterize the ArsM enzyme in vitro. ArsM from R. palustris is distantly related to mammalian Cyt19, which exhibits As(III) AdoMet methyltransferase activity in vitro (7) (8) (9) , but whose physiological function is unknown. R. palustris arsM is induced by the presence of As(III), antimonite, and As(V) in the medium (data not show). The true inducers recognized by ArsR repressors are the trivalent metalloids, but, in vivo, sufficient As(V) can be reduced to As(III) by ArsC reductases (11), of which there are two in R. palustris (Fig. 1) .
As(III) Methylation and Volatilization Confers Resistance. Insertional inactivation of arsM in R. palustris did not result in an increase in As(III) sensitivity compared to the wild type (data not shown), likely due to the presence of multiple arsenic-resistance determinants in R. palustris. For that reason, the R. palustris arsM gene was cloned and expressed in E. coli strain AW3110, which does not have an arsM gene. AW3110 is an arsenic-hypersensitive strain of E. coli lacking the chromosomal arsRBC operon (15) . Expression of arsM allowed for growth in concentrations of As(III) as high as 0.15 mM after more than a day of incubation (data not shown). ArsM has two nonconserved cysteine residues, Cys-281 and Cys-282, in addition to five conserved cysteine residues (Fig. 6 ). Because As(III) binds strongly to vicinal cysteine pairs (16) , these residues were altered to serine residues, producing the ArsMC2 derivative to improve protein production and future crystallization. The activity and function of ArsMC2 was compared to wild-type ArsM in vivo and in vitro. Expression of the gene for ArsMC2 conferred resistance similar to that of the wild type (Fig. 2) , indicating that this vicinal pair, which is not conserved in homologues, does not play a role in methylation. Growth was often preceded by a lag period that was prolonged in higher concentrations of As(III). The lag was longer than the induction period for ArsM (Fig. 2) , suggesting that extended ArsM activity is required before the cells can begin to grow, indicating that As(III) must be metabolized slowly until it decreases to a level permitting growth.
When cells were incubated with As(III) for extended periods, the total amount of arsenic in the culture decreased. The reaction was repeated in a closed vial, and gaseous products were trapped on filters saturated with 6% H 2 0 2 and analyzed for arsenic by HPLC-inductively coupled plasma (ICP)-MS. The amount of volatilized arsenic correlated with the disappearance of solution arsenic (Fig. 3A) . The only arsenical species found on the filter after oxidation by H 2 O 2 was TMAO, which unambiguously identifies the gas as TMA(III). The decrease in As(III) correlated with the appearance of three soluble products in the medium, DMA(V), TMAO, and an unidentified product that did not correspond to any of arsenic standards and TMA(III) in the head space of the reaction vial (Fig. 3B ). These results are strong evidence that formation of methylated arsenicals is responsible for resistance.
Purified ArsM Is an As(III) AdoMet Methyltransferase. Wild-type ArsM and the C281͞282S ArsMC2 variant, both with a His 6 tag, were expressed in E. coli and purified in a single step by Ni(II)-nitrilotriacetic acid (NTA) chromatography. As(III) methylation was assayed by HPLC-ICP-MS. In the absence of glutathione (GSH), no methylated species were formed (Fig.  4A) . Similarly, no methylation was observed in the absence of AdoMet (data not shown). In the presence of ArsM, AdoMet, and GSH, As(III) was converted to DMA(V) (Fig. 4B ). No MMA(V) was observed, nor did ArsM methylate MMA(III) (data not shown). In contrast, if DMA(III) was used as a substrate, TMAO was formed in a time-dependent manner ( (Fig. 5 B and D) was increased Ϸ10-fold, TMAO was formed in the reaction solution ( Fig. 5 A and B) , and an arsenical gas was found in the headspace of the reaction vessel ( Fig. 5 C and D) , whether the wild-type ArsM or the ArsMC2 mutant was used. Because H 2 O 2 oxidized the gas to TMAO, the gas must have been TMA(III). The amount of TMAO in solution was higher at 3 h than at 17 h, and the amount of TMA(III) in the headspace was higher at 17 h than at 3 h, consistent with rapid methylation of As(III) to DMA(V) [probably through a transient intermediate of MMA(V)] and then slower reduction and methylation of DMA(V) to form TMAO. The pentavalent trimethylated species is then reduced to the final product, gaseous TMA(III), which volatilizes into the headspace of the reaction vial and is trapped on the filter as TMAO by oxidation with H 2 O 2 . These results are consistent with sequential formation of mono-, di-, and trimethylated arsenicals, with conversion of As(III) to DMA(V) faster than conversion of DMA(V) to TMAO or TMA(III), as proposed by Challenger (17) . The data demonstrate that ArsM is a methylase, but it is not clear whether ArsM also catalyzes reduction of DMA(V) to DMA(III) or TMAO to TMA(III), or whether the reduction in Fig. 1 . The ars genes of R. palustris CGA009. Shown are the operons of R. palustris that appear to be regulated by an ArsR-type repressor. The first operon (RPA2256, 2257, 2258, 2259) resembles ars operons found in Pseudomonas or Bacillus of the type arsRCBH (ArsR-repressor, ArsC-As(V) reductase, ArsB-As(III) efflux pump, and ArsH-unknown arsenic resistance protein). The arsRM-operon (RPA3561, 3562) encodes the As(III)-methyl-transferase (ArsM) described in this report regulated by an ArsR-type repressor. The third operon (RPA3553-RPA3559) of R. palustris contains two putative arsR genes, two putative As(V) reductases, a putative As(III) permease (acr3), and two genes where the function of the proteins is unknown. The two putative As(III) permeases ArsB and Acr3 belong to two unrelated protein families.
Fig. 2.
ArsM confers resistance to As(III) in E. coli. Resistance to As(III) was assayed in cells of E. coli AW3110(DE3) (⌬arsRBC), bearing vector plasmid pET28a(ϩ) (circle), pET28arsM (encoding wild-type ArsM) (square), or pET28arsMC2 (encoding the ArsMC2 variant) (triangle) were grown with no (white), 50 M (gray), or 70 M (black) sodium As(III) at 37°C, with shaking. Absorbance at 600 nm was monitored by using a SPECTRA max 340PC microplate reader (Molecular Devices) with a path length of 0.24 cm. Shown is the average of three independent assays with standard deviation.
vitro is nonenzymatic. GSH will nonenzymatically reduce As(V) to As(III) in vitro (18) , but reduction in vivo requires an enzyme, such as the ArsC As(V) reductase (19) . At this stage, it is not apparent why the methylation rates were slow in vitro. It is possible that an as yet unidentified methylarsenate reductase works in concert with ArsM in vivo.
Discussion
The methylation of As(III) has been observed in a number of organisms, including humans. For example, higher eukaryotes and bacteria have been reported to produce MMA(V) or DMA(V), and fungi produce trimethylarsine (10) . Methanogens and aerobic eubacteria have also been suggested to form methylated arsines (20, 21) . However, the physiological significance of arsenic methylation is unclear. At first, methylation was thought to be related to arsenic detoxification, because the pentavalent species are relatively innocuous, but, more recently, the process has been suggested to increase arsenic toxicity, because the trivalent species are more toxic than inorganic As(III) (22) . Purified mammalian Cyt19 catalyzes arsenic S-adenosylmethyltransferase activity (23, 24) , but the function of this enzyme in vivo is unknown. Did this enzyme evolve for arsenic detoxification or for another unrelated function? Because the rate of As(III) methylation in cultured primary human hepatocytes does not directly reflect variations in basal mRNA levels for Cyt19 (25) , this activity may be an adventitious methylation reaction unrelated to mammalian physiology.
In contrast, our data show that As(III) methylation in prokaryotes is a previously undescribed detoxification mechanism. The transcriptional regulation of the R. palustris methyltransferase gene shows a direct physiological response to environ- Cells of E. coli strain AW3110(DE3) with vector plasmid pET28a(ϩ) (circle) or plasmid pET28arsMC2 (triangle) were grown in 4 ml of LB medium in the presence of 25 M sodium As(III), and growth was monitored as optical density at 600 nm (gray). Total arsenic in the culture medium (white) and volatilized arsenic (black) were determined as described above. (B) Speciation of arsenic in the culture medium. Cultures were grown for 18 h after the determination of the arsenic species in the medium by HPLC-ICP-MS using known standards of As(III), As(V), DMA(V), and TMAO. The unknown peak did not correspond to any of the standards. Black bars indicate the arsenic species at time point 0, white bars, after 18 h of cultivation. mental arsenic (data not shown). In response, the cells methylate As(III) to the relatively nontoxic pentavalent species DMA(V) and TMAO. The more toxic MMA(III) and DMA(III) are probably transient intermediates that do not accumulate. Even though the final product is trivalent TMA(III), its volatilization lowers the arsenical concentration in both the medium and cytosol, augmenting detoxification. This arsenical resistance is reminiscent of selenium detoxification, in which volatile dimethyl selenide and dimethyl diselenide are formed in bacteria and plants (14, 26) , and of MerA-mediated mercury detoxification, in which Hg(II) is reduced to volatile Hg(0) (27) .
Methylation of As(III) by ArsM homologues contributes to the global cycling of arsenic. Bacteria and fungi, which also have ArsM homologues, methylate arsenic to volatile species such as TMA (10) . This biogenic source of gaseous arsenic has been estimated to produce 8-fold more atmospheric arsenic than does continental dust (28) . TMA(III) is also an intermediate in the formation of other organoarsenicals. O-phosphotidyltrimethylarsonium lactic acid, which is found in marine algae and animals, is formed by nucleophilic reaction of phosphoenolpyruvate and TMA(III) (29) . A degradation product of O-phosphotidyltrimethylarsonium lactic acid is arsenobetaine, which is found in marine animals, such as Western rock lobster and dusky shark, and arsenosugars found in brown kelp could also be derived from TMA(III) (30) . Thus, arsenic methylation may be a protective mechanism for individual organisms and is an important link in the global arsenic cycle (31).
Materials and Methods
Chemicals. As(V), As(III), and DMA(V) were obtained from Sigma, MMA(V) was obtained from Chem Service (West Chester, PA), MMA(III) was a gift from Miroslav Styblo (University of North Carolina, Chapel Hill, NC), TMAO was a gift from Tim McDermott (Montana State University, Bozeman, MT). The reagents used for HPLC-ICP-MS, including tetrabutylammonium hydroxide and malonic acid, were obtained from Sigma.
Bacterial Strains, Media, and Growth Conditions. R. palustris strain CGA009 was a gift from Caroline Harwood, University of Iowa (Iowa City, IA). Cultures were grown at 30°C anaerobically in the light in photosynthetic medium (32) . Sterile solutions of sodium succinate and sodium bicarbonate were added to final concentrations of 10 mM after autoclaving of the medium. Agar was autoclaved separately. When appropriate, kanamycin and tetracycline were added to final concentrations of 0.2 mg͞ml and 25 g͞ml, respectively.
E. coli strains were grown aerobically at 37°C in LB medium (33) , supplemented with 0.1 mg͞ml ampicillin, 25 g͞ml kanamycin, 12.5 g͞ml tetracycline, or 25 g͞ml chloramphenicol, as required. Strain DH5␣ (Promega) was used for plasmid construction and replication, and strain S17-1 (Biomedal, Seville, Spain) served as the plasmid donor in conjugation with R. palustris. Strain AW3110(DE3) (⌬arsRBC; ArsR-repressor; ArsB-As(III) efflux pump; and ArsC-As(V) reductase) (15), which is hypersensitive to As(III), was used for complementation studies. Strain BL21(DE3) (Novagen) was used for protein expression. Bacterial growth was monitored by measuring the optical density at 600 nm.
DNA and RNA Manipulations. Genomic DNA of R. palustris was isolated by using Genomic-Tip 20͞G and Buffer set (Qiagen, Valencia, CA) following the manufacturer's protocol. Isolation of plasmid DNA was performed by using a QIAPrep Spin Miniprep kit (Qiagen). Total RNA of R. palustris was isolated by using an RNeasy kit (Qiagen) following the manufacturer's protocol. Because of the extremely high GC content (65% on average) of the R. palustris genome, PCR reactions were modified by supplementation of 10% (vol͞vol) DMSO when using R. palustis DNA as templates to enhance amplification of DNA targets. Transfer of plasmid vectors into R. palustris cells was accomplished by bacterial mating with E. coli S17-1 donor cells (34) .
Construction of arsM Overexpression Vectors. To express ArsM from R. palustris in E. coli, a 0.85-kb fragment containing the ATG start codon and excluding the stop codon was PCR amplified from R. palustis genomic DNA by using the primers 3Ј arsM (AAACTGCAGCCCGCAGCAGCGCGCCG) (KpnI site underlined) and 5Ј arsM (AAAGGTACCATGCCCACTGA-CATGCAAGACGTGA) (PstI site underlined). After digestion with KpnI and PstI, arsM was cloned into KpnI͞PstI-digested vector pASK-IBA3 (IBA Göttingen, Germany), resulting in plasmid pASKarsM. Subsequently, a 0.85-kb NcoI-HindIII fragment containing the arsM gene (primer 5Ј arsMw: GGTGGTC-CATGGCCACTGACATGCAAGACGTGAAG (NcoI site underlined) and 3Ј arsMw: GCGGCCAAGCTTAATGATG-ATGATGATGATGCCCGCAGCAGCGCGCCGGCACC (HindIII site underlined)) was PCR amplified from pASKarsM and inserted into pET28a(ϩ), generating plasmid pET28arsM, in which the arsM gene is under the control of the T7 promoter. The primer 5Ј arsMw introduces the codons for His 6 residues exactly after the last amino acid residue at the C terminus of ArsM, creating a C-terminal His-tagged ArsM of 289 amino acid residues and mass of 30,452 Da. To shorten the fusion, the NcoI site on vector pET28a(ϩ) was used, which changed the second amino acid residue from proline to alanine. A 0.58-kb AscIHindIII fragment of the arsM gene was PCR amplified from pET28arsM and substituted with a AscI-HindIII fragment generated by using primer 5Ј arsMC2 (GTCGGCGCGC-CGGGTCGGCCCGACCGGCAAAGCCTACGGCCT) (AscI site underlined) and 3Ј arsMC2 (GGTGGTAAGCTTAATGA-TGATGATGATGATGCCCGGAGGAGCGCGCCGGCAC-CTCGCCGTCC) (HindIII site underlined) to produce the ArsMC2 mutant. This mutant, in which Cys-281 and Cys-282 were altered to serine residues, was constructed to examine whether those two cysteines were required for ArsM activity. Because the properties of ArsMC2 and wild-type ArsM enzymes turned out to be comparable (see below), in some experiments, the derivative was used in place of the wild-type enzyme. All of the sequences were verified by DNA sequencing.
Construction of an arsM Gene Deletion in R. palustris. The arsM gene was deleted by homologous recombination by using the cre-lox system (35) . Primers 5Ј arsM1 (AAAGAATTCAAGCCG-GCTCGCGCGAAGA) (EcoRI site underlined), 3Ј arsM1 (AAACCATGGTGTCAGTGGGCATTGCGGTT) (NcoI site underlined), 5Ј arsM2 (AAAGGGCCCAGACTTCTCAGC-CCGTCATTGC) (ApaI site underlined), and 3Ј arsM2 (AAA-GAGCTCCAGCAACCAATGACACTCAGGC) (SacI site underlined) were used to amplify 0.6-kb DNA fragments directly up-and downstream of arsM by PCR. These two fragments, designated arsM1 (upstream of arsM) and arsM2 (downstream of arsM), were cloned into the plasmid vector pGEM-T EASY (Promega), leading to pGEMM1 and pGEMM2 for sequence verification. The arsM2 gene was subcloned into plasmid pCM184 (35) upstream of the kanamycin cassette at the ApaI͞ SacI sites, creating plasmid pCMM2. Subsequently, arsM1 was EcoRI͞NcoI digested and subcloned into pCMM2 downstream of the kanamycin cassette, leading to plasmid pCMM21. By using E. coli S17-1, pCMM21 was conjugated into R. palustris CGA009, and arsM was replaced by the kanamycin cassette in a doublerecombination event. The deletion was verified by PCR and Southern blotting.
Northern Blot Analysis. A single colony of R. palustris was inoculated into 5 ml of photosynthetic medium (PM) and incubated at 30°C for one week. The culture was diluted 1:500 into PM medium supplemented with 10 M sodium As(III), 0.1 mM sodium As(V), or 5 M potassium antimonyl tartrate and incubated until the cultures attained an OD 600 of 0.5, after which higher concentrations of sodium As(III) (0.1 mM), sodium As(V) (1 mM), or potassium antimonyl tartrate (0.05 mM) were added to the respective cultures. After an additional 6 h, total RNA was isolated, separated by formaldehyde gel electrophoresis, transferred to a Hybond-A nylon membrane, and hybridized with 100 g͞ml [␥-
32 P]-labeled single-stranded arsM-DNA probe by using the RadPrime DNA labeling system (Invitrogen) at 42°C overnight.
Resistance Assays. Single colonies of E. coli strain AW3110(DE3) (⌬ars) and AW3110(DE3) pET28arsM were inoculated into 5 ml of LB medium supplemented with the appropriate antibiotics and incubated at 37°C overnight. Late exponential phase cells were diluted 50-fold into 50 ml of LB medium containing 25 g͞ml kanamycin, 0.3 mM isopropyl ␤-D-thiogalactoside (IPTG), and the indicated concentrations of sodium As(III). Growth was monitored as optical density at 600 nm and continued until the cultures reached stationary phase.
ArsM Purification. Cells of BL21(DE3) pET28arsM were grown at 37°C in LB medium to an OD 600 of 0.5, at which point 0.3 mM IPTG was added to induce expression of His-tagged ArsM or ArsMC2. The cells were grown for another 4 h, harvested by centrifugation (5,000 ϫ g) at 4°C for 20 min, washed once with a buffer A (50 mM Mops, pH 7.5, containing 20% (wt͞vol) glycerol, 0.5 M NaCl, 20 mM imidazole, and 10 mM 2-mercaptoethanol), and suspended in 5 ml of buffer A per g of wet cells. The cells were lysed by a single pass through a French-press cell at 20,000 psi, and 2.5 l per g wet cell of di-isopropyl fluorophosphate was added immediately. Membranes and unbroken cells were removed by centrifugation at 150,000 ϫ g for 1 h, and the supernatant solution was loaded at a flow rate of 0.5 ml͞min onto a Ni(II)-NTA column preequilibrated with buffer A. The column was then washed with 150 ml of buffer A, followed by elution with 60 ml of buffer A, with the concentration of imidazole increased to 0.2 M. ArsM was identified by sodiumdodecyl-sulfate polyacrylamide gel electrophoresis. Fractions containing ArsM were concentrated by centrifugation using a 10-kDa-cutoff Amicon Ultrafilter (Millipore). Protein concentrations were estimated by the method of Bradford (Bio-Rad Protein Assay 500-0006) using BSA (Sigma) as a standard.
Arsenic Speciation. Protein was removed from the reaction samples by centrifugation using a 10-kDa-cutoff Amicon Ultrafilter (Millipore). The filtrate was then speciated by HPLC (Series 2000, PerkinElmer) ICP-MS (ELAN 9000, PerkinElmer) using either a reverse-phase C18 column (Jupiter 300) eluted isocratically with a mobile phase consisting of 3 mM malonic acid, 5 mM tetrabutylammonium hydroxide, and 5% methanol, pH 5.6, with
